|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Editas Medicine (NASDAQ: EDIT) through any online brokerage.
The latest price target for Editas Medicine (NASDAQ: EDIT) was reported by RBC Capital on 2021-05-04. The analyst firm set a price target for 40.00 expecting EDIT to rise to within 12 months (a possible 17.27% upside). 19 analyst firms have reported ratings in the last year.
The stock price for Editas Medicine (NASDAQ: EDIT) is $34.11 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Editas Medicine.
There is no upcoming split for Editas Medicine.